Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases

Cytogenetics and Cell Genetics

Volumn 88, Issue 1-2, 2000, Pages 82-86

  Guenet, Lucienne ^a   Henry, C ^b   Toutain, B ^a   Dubourg, C ^a   Le Gall, J Y ^a   David, V ^a   Le Treut, A ^a  

^a Inst de Rech Contre le Cancer IRCC   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TRANSLATION TERMINATION FACTOR;

ARTICLE; CHROMOSOME 5Q; CHROMOSOME 6; CHROMOSOME 7; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOGENE; X CHROMOSOME;

EUKARYOTA;

EID: 0034104651     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015491     Document Type: Article

References (31)

1. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 25:3389-3402 (1997).
2. Amiel A, Fridman K, Elis A, Gaber E, Manor Y, Fejgin M, Lishner M: Deletion 5q31 in patients with stable, melphalan-treated multiple myeloma. Cancer Genet Cytogenet 113:45-48 (1999).
3. Bartoloni L, Horrigan SK, Viles KD, Gilchrist JM, Stajich JM, Vance JM, Yamaoka LH, Pericak-Vance MA, Westbrook CA, Speer MC: Use of a CEPH meiotic breakpoint panel to refine the locus of limb-girdle muscular dystrophy type 1A (LGMD1A) to a 2-Mb interval on 5q31. Genomics 54:250-255 (1998).
4. Chauvel B, Dorval I, Fergelot P, Pichon L, Giffon T, Gicquel I, Le Gall JY, David V: A human homologue to the yeast omnipotent suppressor 45 maps 100 kb centromeric to HLA-A. Immunogenetics 41:380-382 (1995).
5. Chumakov IM, Rigault P, LeGall I, Bellanne-Chantelot C, Billault A, Guillou S, Soularue P, Guasconi G, Poullier E, Gros I, et al: A YAC contig map of the human genome. Nature 377:175-297 (1995).
6. Drugeon G, Jean-Jean O, Frolova L, Le Goff X, Philippe M, Kisselev L, Haenni AL: Eukaryotic release factor 1 (eRF1) abolishes readthrough and competes with suppressor tRNAs at all three termination codons in messenger RNA. Nucl Acids Res 25:2254-2258 (1997).
7. El Kahloun A, Chauvel B, Mauvieux V, Dorval I, Jouanolle AM, Gicquel I, Le Gall JY, David V: Localization of seven new genes around the HLA-A locus. Hum Mol Genet 2:55-60 (1993).
8. Fairman J, Chumakov I, Chinault AC, Nowell PC, Nagarajan L: Physical mapping of the minimal region of loss in 5q-chromosomc. Proc natl Acad Sci. USA 92:7406-7410 (1995).
9. Feit H, Silbergleit A, Schneider LB, Gutierrez JA, Fitoussi RP, Réyès C, Rouleau GA, Brais B, Jackson CE, Beckmann JS, Seboun E: Vocal cord and pharyngeal weakness with aulosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am J hum Genet 63:1732-1742 (1998).
10. Frolova L, Le Goff X, Rasmussen HH, Cheperegin S, Drugeon G, Kress M, Arman I, Haenri AL, Celis JE, Philippe M, Justesen J, Kisselev L: A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature 372:701-703 (1994).
11. Grenett HE, Bounelis P, Fuller GM: Identification of a human cDNA with high homology to yeast omnipotent suppressor 45. Gene 110:239-243 (1992a).
12. Grenett HE, Eipers PG, Kidd VJ, Bounelis P, Fuller GM: Chromosomal localization of a human cDNA containing a DIDS binding domain and demonstrating high homology to yeast omnipotent suppressor 45. Somat Cell Mol Genet 18:97-102 (1992b).
13. Guenet L, Toutain B, Guilleret I, Chauvel B, Deaven LL, Longmire JL, Le Gall JY, David V, Le Treut A: Human release factor eRF1: structural organisation of the unique functional gene on chromosome 5 and of the three processed pseudogenes. FEBS Lett 454:131-136 (1999).
14. Horrigan SK, Bartoloni L, Speer MC, Fulton N, Kravarusic J, Ramesar R, Vance JM, Yamaoka LH, Westbrook CA: A radiation hybrid breakpoint map of the acute myeloid leukemia (AML) and limb-girdle muscular dystrophy 1A (LGMD1A) regions of chromosome 5q31 localizing 122 expressed sequences. Genomics 57:24-35 (1999).
15. Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson RA: Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 88:2665-2670 (1996).
16. - syndrome. Genes Chrom Cancer 22:251-256 (1998).
17. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 4:325-345 (1986).
18. Le Beau MM, Espinosa R III, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook CA: Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc natl Acad Sci. USA 90:5484-5488 (1993).
19. Le Goff X, Philippe M, Jean-Jean O: Overexpression of human release factor 1 alone has an antisuppressor effect in human cells. Mol Cell Biol 17:3164-3172 (1997).
20. - chromosome. Blood 83:199-208 (1994).
21. - abnormality. Blood 70:1705-1712 (1987).
22. Rihet P, Traore Y, Abel L, Aucan C, Traore-Leroux T, Fumoux F: Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31 →q33. Am J hum Genet 63:498-505 (1998).
23. Saltman DL, Dolganov GM, Warrington JA, Wasmuth JJ, Lovett M: A physical map of 15 loci on human chromosome 5q23→q33 by two-color fluorescence in situ hybridization. Genomics 16:726-732 (1993).
24. Spring B, Fonatsch C, Muller C, Pawelec G, Kompf J, Wernet P, Ziegler A: Refinement of HLA gene mapping with induced B-cell line mutants. Immunogenetics 21:277-291 (1985).
25. Troye Blomberg M, Berzins K, Perlmann P: T-cell control of immunity to the asexual blood stages of the malaria parasite. Crit Rev Immunol 14:131-155 (1994).
26. Urbero B, Eurwilaichitr L, Stanfield I, Tassan JP, Le Goff X, Kress M, Tuite MF: Expression of the release factor eRF1 (Sup45p) gene of higher eukaryotes in yeast and mammalian tissues. Biochimie 79:27-36 (1997).
27. Viegas-Péquignot E, Dutrillaux B, Magdelenat H, Copey-Moisan M: Mapping of single-copy DNA sequences on human chromosomes by in situ hybridization with biotinylated probes: enhancement of detection sensitivity by intensified-fluorescence digital-imaging microscopy. Proc natl Acad Sci USA 86:582-586 (1989).
28. Warrington JA, Hall LV, Hinton LM, Miller JN, Wasmuth JJ, Lovett M: Radiation hybrid map of 13 loci on the long arm of chromosome 5. Genomics 11:701-708 (1991).
29. Warrington JA, Bailey SK, Armstrong E, Aprelikova O, Alitalo K, Dolganov GM, Wilcox AS, Sikela JM, Wolfe SF, Lovett M, Wasmuth JJ: A radiation hybrid map of 18 growth factor, growth factor receptor, hormone receptor, or neurotransmitter receptor genes on the distal region of the long arm of chromosome 5. Genomics 13:803-808 (1992).
30. Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R, Larson RA, Le Beau MM: Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant mycloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc natl Acad Sci. USA 94:6948-6953 (1997).
31. Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov S, Kisselev L, Philippe M: Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 14:4065-4072 (1995).